Skip to content
OpenCapital
Get started

AirSculpt Technologies, Inc. AIRS EV / sales

EV / sales at other companies

Eli Lilly logo
Eli LillyLLY
11.9×-4.0×
AbbVie logo
AbbVieABBV
7.5×+1.0×
Establishment Labs logo
Establishment LabsESTA
8.1×+0.2×
Bausch Health Companies logo
Bausch Health CompaniesBHC
2×-0.3×

Other financials

Income statement

See full
Revenue$39.4M0.0%
Gross profit$23.8M+1.6%
Operating income-$1.8M-13.4%
Net income-$2.4M+15.8%
EPS (diluted)-$0.03+40.0%

Balance sheet

See full
Cash & equivalents$16.7M+201%
Total debt$71.0M-27.1%
Total equity$100.3M+31.5%
Total assets$192.0M-5.5%

Cash flow

See full
Operating cash flow$5.3M+507%
CapEx$51.0K-97.3%
Free cash flow$5.2M+605%

Valuation

See full
Market cap$311.81M+4.7%
Enterprise value$366.14M-6.0%
P/S2.1×+0.3×

Profitability

See full
Gross margin59.6%-0.3pp
Operating margin-7.8%-0.4pp
Net margin-11.3%-25.1pp
FCF margin-0.1%—

Returns & leverage

See full
Return on equity-21.6%-78.3pp
Debt / equity0.7×-0.6×
Current ratio0.7×+0.2×

Where this comes from

Calculated from AirSculpt Technologies, Inc.’s reported figures.

enterprise value/total revenue=1.5×

Based on the most recent quarter.

The official record: AirSculpt Technologies, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about AirSculpt Technologies, Inc.'s ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AirSculpt Technologies, Inc.'s EV / sales?
AirSculpt Technologies, Inc. (AIRS) reported EV / sales of 1.5× in Q1 2026.
How has AirSculpt Technologies, Inc.'s EV / sales changed year-over-year?
AirSculpt Technologies, Inc.'s EV / sales increased by 14.5% year-over-year, from 1.3× to 1.5×.
What is the long-term trend for AirSculpt Technologies, Inc.'s EV / sales?
Over 4 years (2021 to 2025), AirSculpt Technologies, Inc.'s EV / sales has grown at a -35.9% compound annual growth rate (CAGR), from 7.7× to 1.3×.
What does EV / sales mean?
Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.